Characteristics of included studies used to calculate pooled prevalence of SCT among patients with CKD/ESRD
| Author, year . | Country . | Total sample . | No of SCT . | Sites of enrollment . | SCT diagnosis . | CKD/ESRD diagnosis . | Cohort characteristics . |
|---|---|---|---|---|---|---|---|
| Derebail et al,36 2014 | United States | 5319 | 542 | Patients undergoing hemodialysis at 117 in-center hemodialysis clinics from Eastern United States | Hb electrophoresis | Patients in dialysis treatment | Mean age (SD): 60.1 (14.1) years Male: 50.6% Hypertense: NI Diabetic: 51.7% |
| Derebail et al,35 2010 | United States | 187 | 28 | 4 dialysis units in North Carolina | HPLC | Patients in dialysis treatment | Mean age (SD): 59.3 (14.7) years Male: 52.4% Hypertense: 36.4% Diabetic: 40.1% |
| Hicks et al,27 2011 | United States | 2081 | 164 | Patients with ESRD from North Carolina, South Carolina, Georgia, Virginia, or Tennessee | Direct genotyping | Patients in dialysis treatment | Mean age (SD): 57.8 (12.5) years Male: 48.2% Hypertense: NI Diabetic: 47.9% |
| Mukendi et al,26 2015 | Africa | 188 | 39 | Patients from secondary and tertiary care hospitals in the Democratic Republic of the Congo | Electrophoresis | eGFR <60 mL/min per 1.73 m2 | Mean age (SD): 55.5 (16) years Male: 48.8% Hypertense: 39% Diabetic: 44% |
| Sood et al,34 2019 | United States | 652 | 65 | 11 clinical centers located in Cleveland, Ohio; Nashville, Tennessee; Dallas, Texas; Baltimore, Maryland; Washington, DC; Atlanta, Georgia; and Los Angeles, California | Genotyping | Hypertension-attributed CKD (mGFR 20-65 mL/min per 1.73 m2) | Mean age (SD): 54 (10.8) years Male: 59.8% Hypertense: 100% Diabetic: NI |
| Author, year . | Country . | Total sample . | No of SCT . | Sites of enrollment . | SCT diagnosis . | CKD/ESRD diagnosis . | Cohort characteristics . |
|---|---|---|---|---|---|---|---|
| Derebail et al,36 2014 | United States | 5319 | 542 | Patients undergoing hemodialysis at 117 in-center hemodialysis clinics from Eastern United States | Hb electrophoresis | Patients in dialysis treatment | Mean age (SD): 60.1 (14.1) years Male: 50.6% Hypertense: NI Diabetic: 51.7% |
| Derebail et al,35 2010 | United States | 187 | 28 | 4 dialysis units in North Carolina | HPLC | Patients in dialysis treatment | Mean age (SD): 59.3 (14.7) years Male: 52.4% Hypertense: 36.4% Diabetic: 40.1% |
| Hicks et al,27 2011 | United States | 2081 | 164 | Patients with ESRD from North Carolina, South Carolina, Georgia, Virginia, or Tennessee | Direct genotyping | Patients in dialysis treatment | Mean age (SD): 57.8 (12.5) years Male: 48.2% Hypertense: NI Diabetic: 47.9% |
| Mukendi et al,26 2015 | Africa | 188 | 39 | Patients from secondary and tertiary care hospitals in the Democratic Republic of the Congo | Electrophoresis | eGFR <60 mL/min per 1.73 m2 | Mean age (SD): 55.5 (16) years Male: 48.8% Hypertense: 39% Diabetic: 44% |
| Sood et al,34 2019 | United States | 652 | 65 | 11 clinical centers located in Cleveland, Ohio; Nashville, Tennessee; Dallas, Texas; Baltimore, Maryland; Washington, DC; Atlanta, Georgia; and Los Angeles, California | Genotyping | Hypertension-attributed CKD (mGFR 20-65 mL/min per 1.73 m2) | Mean age (SD): 54 (10.8) years Male: 59.8% Hypertense: 100% Diabetic: NI |
mGFR, measured glomerular filtration rate; NI, not included; SD, standard deviation.